IRIS PubliCatt

Scaldaferri, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.534
NA - Nord America 5.491
AS - Asia 1.605
SA - Sud America 45
AF - Africa 38
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 17
Totale 12.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.444
DE - Germania 1.336
SE - Svezia 1.241
IT - Italia 1.040
CN - Cina 847
FR - Francia 357
IE - Irlanda 335
UA - Ucraina 328
PL - Polonia 256
SG - Singapore 241
GB - Regno Unito 160
IN - India 127
FI - Finlandia 123
RU - Federazione Russa 121
TR - Turchia 104
IR - Iran 83
KR - Corea 45
HK - Hong Kong 40
BE - Belgio 38
NL - Olanda 35
CA - Canada 33
ES - Italia 32
JP - Giappone 31
CZ - Repubblica Ceca 28
BR - Brasile 24
CI - Costa d'Avorio 19
VN - Vietnam 17
AU - Australia 16
EU - Europa 16
CH - Svizzera 14
RO - Romania 13
BG - Bulgaria 12
IQ - Iraq 12
TW - Taiwan 12
MX - Messico 11
CL - Cile 10
PH - Filippine 10
AT - Austria 9
IL - Israele 7
PT - Portogallo 7
HU - Ungheria 6
LT - Lituania 6
PE - Perù 6
SI - Slovenia 6
ZA - Sudafrica 6
EG - Egitto 5
ID - Indonesia 5
NZ - Nuova Zelanda 5
GR - Grecia 4
HR - Croazia 4
TH - Thailandia 4
AR - Argentina 3
CY - Cipro 3
EE - Estonia 3
MK - Macedonia 3
NG - Nigeria 3
PK - Pakistan 3
AL - Albania 2
BD - Bangladesh 2
BZ - Belize 2
DK - Danimarca 2
KW - Kuwait 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
GE - Georgia 1
GH - Ghana 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
Totale 12.751
Salva come PNG Salva come JPEG
Città #
Chandler 1.397
Ashburn 488
Dublin 330
Jacksonville 239
Warsaw 226
San Mateo 202
New York 175
Ann Arbor 167
Rome 162
Wilmington 154
Singapore 147
Beijing 144
Boston 141
Nanjing 139
Cattolica 125
Milan 119
Marseille 116
Princeton 115
Fairfield 102
Dearborn 90
Woodbridge 88
Moscow 85
Redwood City 85
Houston 76
Seattle 72
Nürnberg 71
Izmir 68
Lawrence 62
Boardman 61
Bremen 58
Munich 54
Hangzhou 53
Nanchang 45
Redmond 42
Shanghai 37
Hebei 36
Helsinki 35
Augusta 34
Pune 34
Mountain View 33
Lancaster 32
Cambridge 31
Shenyang 30
Chicago 29
Brussels 28
Tianjin 28
London 27
Los Angeles 27
Kunming 26
Norwalk 26
Changsha 25
Detroit 25
Seoul 25
Zhengzhou 25
Washington 24
Kish 22
Trieste 22
Jiaxing 21
Kraków 21
Fremont 20
Abidjan 19
Guangzhou 18
Andover 17
Leawood 17
Monza 15
Naples 15
Paris 14
Central 13
San Diego 13
Brno 12
Hefei 12
University Park 12
Busto Arsizio 11
Lappeenranta 11
Tehran 11
Hong Kong 10
Jinan 10
Tokyo 10
Berlin 9
Cagliari 9
Falls Church 9
Hanoi 9
Lanzhou 9
Zurich 9
Florence 8
Goyang-si 8
Monmouth Junction 8
Stockholm 8
São Paulo 8
Vienna 8
Ardabil 7
Atlanta 7
Baghdad 7
Bari 7
Frankfurt am Main 7
Madrid 7
San Francisco 7
Sofia 7
Toronto 7
Ceska 6
Totale 6.832
Salva come PNG Salva come JPEG
Nome #
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 422
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 292
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 196
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 188
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 157
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 151
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 151
Management of acute dyarrhea: current and future trends 139
The role of diet on gut microbiota composition 136
The gut barrier: new acquisitions and therapeutic approaches 135
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 132
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 132
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 129
13C-octanoic acid breath test to study gastric emptying time 126
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 126
Bacterial flora as a cause or treatment of chronic diarrhea 125
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 125
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 118
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 113
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 113
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 112
Assessment of neurological manifestations in hospitalized patients with COVID-19 112
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 111
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 108
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 108
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 103
Dietary magnesium: the magic mineral that protects from colon cancer? 100
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 100
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 99
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 94
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 94
Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome 92
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers 92
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 91
The gastrointestinal microbiome - functional interference between stomach and intestine 91
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 90
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease 90
Differential CD133 expression pattern during mouse colon tumorigenesis 88
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 88
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 87
Origin of celiac disease: How old are predisposing haplotypes? 86
Use and indications of cholestyramine and bile acid sequestrants 86
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 86
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 86
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 86
Use and indications of cholestyramine and bile acid sequestrants 85
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 85
European consensus conference on faecal microbiota transplantation in clinical practice 85
-Extraintestinal manifestations in inflammatory Bowel disease. 84
A novel pathogenic role for microvasculature in inflammatory bowel disease. 84
Commensal Clostridia: leading players in the maintenance of gut homeostasis 84
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 83
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients 83
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 82
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 80
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials 79
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 79
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 79
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 76
Small bowel bacterial overgrowth and type 1 diabetes 75
Bacillus clausii and gut homeostasis: state of the art and future perspectives 75
Pancreatic function assessment 74
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy) 73
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 73
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 69
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 68
Gut microbiota and inflammatory bowel disease: an update 68
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 68
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 68
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 67
Endoscopic ultrasound-guided fine-needle tissue acquisition from a subepithelial lesion in the distal ileum using the forward-viewing echoendoscope 65
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 65
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 65
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 65
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 65
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 63
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals 63
The current practice of lynch syndrome diagnosis and management in Italy: A qualitative assessment 63
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 63
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 62
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 62
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment. 60
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 60
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 60
Cancer and Mediterranean Diet: A Review 60
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 59
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 59
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 58
Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy 57
Acute refractory intestinal pseudo-obstruction in melas: Efficacy of prucalopride 57
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) 57
Editorial--Is there still a place for breath tests in gastroenterology? 56
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 56
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 56
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 55
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 55
Can we predict the efficacy of anti-TNF-α agents? 54
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 54
Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. 54
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 53
Totale 9.293
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.418 268 106 89 51 90 106 158 72 121 86 173 98
2020/20211.193 58 141 20 116 176 89 133 24 126 75 202 33
2021/20221.744 120 83 37 101 123 57 26 241 86 190 345 335
2022/20233.959 513 511 297 601 238 467 195 343 455 80 161 98
2023/20242.401 105 537 99 153 100 317 186 94 127 135 264 284
2024/202568 68 0 0 0 0 0 0 0 0 0 0 0
Totale 13.031